Thrombolytic therapy should be initiated within what time frame of an ischemic stroke to achieve the best functional outcome?

Reasoning:

Choice A reason: Iron deficiency anemia is a risk post-gastric bypass due to reduced stomach acid and bypassed duodenum, impairing iron absorption. Pantoprazole, a proton pump inhibitor, further reduces acid, exacerbating malabsorption. Fatigue results from low hemoglobin, as iron is essential for red blood cell production, matching the client’s profile.

Choice B reason: Aplastic anemia, caused by bone marrow failure, is not linked to gastric bypass or pantoprazole. It results from autoimmune, toxic, or idiopathic causes, leading to pancytopenia. The client’s surgical history and medication use point to malabsorption, not bone marrow suppression, ruling out this anemia.

Choice C reason: Sickle cell anemia is an inherited hemoglobinopathy, not related to gastric bypass or pantoprazole. It causes hemolytic anemia and vaso-occlusive crises, not malabsorption-related fatigue. The client’s surgical history suggests an acquired nutritional deficiency, making iron deficiency more likely than sickle cell disease.

Choice D reason: Pernicious anemia results from vitamin B12 deficiency, often due to lack of intrinsic factor, which may occur post-gastric bypass. However, pantoprazole primarily impairs iron absorption, and fatigue with this history points to iron deficiency, as B12 absorption is less affected in this scenario.

Reasoning:

Choice A reason: Carotid endarterectomy (CEA) does not determine the cause of TIAs but treats them by removing plaques. Diagnostic tests like carotid ultrasound identify atherosclerosis as the cause. CEA addresses the known obstruction, preventing further ischemic events, not investigating their etiology.

Choice B reason: CEA removes atherosclerotic plaques from the carotid artery, restoring blood flow to the brain. TIAs often result from plaque-induced stenosis, causing transient ischemia. By clearing the blockage, CEA prevents recurrent TIAs and strokes, directly addressing the underlying cause of cerebral hypoperfusion.

Choice C reason: Preventing seizure activity is not the purpose of CEA. Seizures are not common after TIAs, which are transient ischemic events without permanent damage. CEA targets vascular stenosis to prevent ischemia, not neurological complications like seizures, which are unrelated to its mechanism.

Choice D reason: Decreasing cerebral edema is not a goal of CEA. Edema is more associated with hemorrhagic stroke or severe ischemia, not TIAs. CEA restores blood flow by removing plaques, preventing ischemic events, not addressing brain swelling, which requires different interventions like mannitol.